Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

John Kiely

At a glance: John Kiely is Director at Amneal Pharmaceuticals (AMRX). Their latest SEC Form 4, filed Aug 14, 2026, reported a sale of $882K. On file: 0 purchase lines ($0) and 1 sale line ($882K).

Disclosed holdings: about $4.5M of AMRX stock: 210,252 shares reported on their latest Form 4 (filed Aug 14, 2026), valued at the Nov 20, 2026 close of $21.29. This counts only AMRX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Amneal Pharmaceuticals, Inc. (AMRX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $882K

John Kiely's InsiderPrint

3 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.

InsiderPrint of John Kiely: 3 trades, 2020 to 20262020: 2 buys, 0 sales2021: 0 buys, 0 sales2022: 0 buys, 0 sales2023: 0 buys, 0 sales2024: 0 buys, 0 sales2025: 0 buys, 0 sales2026: 0 buys, 1 sale

Reading this print: Mostly buys, trading about once a year, typically $44K a trade.

  • Bump outward: a purchase (2)
  • Dent inward: a sale (1)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Frank P. LanutoSee Remarks · STGW · 100% match
  2. Marc SuidanCFO · BLZE · 100% match
  3. Deval L. PatrickDirector · TOST · 99% match
  4. Mark E. Ferguson IIIDirector · PCG · 99% match
  5. Laura C. KendallDirector · HTB · 99% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Every purchase since 2020

From the SEC's insider data sets: each open-market buy by John Kiely, matched to how the stock did over the next 90 days against the S&P 500.

0 of 1 buy beat the S&P 500 (0%), median -20.7% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
AMRXMay 19, 2020-20.7%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Aug 14SEC AMRXAmneal Pharmaceuticals, Inc. Sell 50,000210,252 held (−19%) $17.64 $882K +20.7%

Follow John Kiely

Get one email when John Kiely files a new purchase or sale. Free.

At most one email a day about John Kiely, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.